Long term ketamine and ketamine plus alcohol toxicity - what can we learn from animal models?

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 2, 2013, Pages 273-279

  Wai, M S M ^a   Luan, P ^b   Jiang, Y ^c   Chan, W M ^a   Tsui, T Y M ^a   Tang, H C ^a   Lam, W P ^a   Fan, M ^d   Yew, D T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHENZHEN UNIVERSITY   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Alcohol; Animal; Cerebellum; Interaction; Ketamine; Liver; Toxicity; Urinary

Indexed keywords

ALCOHOL; CAFFEINE; HYDROQUINONE; KETAMINE; LIVER ENZYME; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TAU PROTEIN;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BLADDER DISEASE; BRAIN CORTEX; CONVULSION; CYSTITIS; DELIRIUM; DIZZINESS; DOWN REGULATION; DRUG MEGADOSE; EXCITOTOXICITY; FIBROSIS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENITAL SYSTEM DISEASE; HEADACHE; HEART INJURY; HUMAN; HYPERACTIVITY; INTOXICATION; KIDNEY FIBROSIS; MENTAL DISEASE; NAUSEA; NERVE CELL DEGENERATION; NONHUMAN; PROTEINURIA; PURKINJE CELL; RECOMMENDED DRUG DOSE; SENSORIMOTOR CORTEX; SIDE EFFECT; STUPOR; SWEATING; TINNITUS; TREMOR; UPREGULATION;

EID: 84876863185     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955713804805210     Document Type: Article

References (32)

1. Bergman, S.A. Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog., 1999, 46, 10-20.
2. Reboso Morales, J.A.; González Miranda, F. [Ketamine]. Rev Esp Anestesiol Reanim., 1999, 46, 111-122.
3. Harrison, N.L.; Simmonds, M.A. Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br. J. Pharmacol., 1985, 84, 381-391.
4. Sinner, B.; Graf, B.M. Ketamine. Handb Exp. Pharmacol., 2008, 182, 313-333.
5. Narcotics Division, Security Bureau, The Government of the Hong Kong Special Administrative Region. http://www.nd.gov.hk/tc/index.htm
6. Lankenau, S.E.; Sanders, B.; Bloom, J.J.; Hathazi, D.; Alarcon, E.; Tortu, S.; Clatts, M.C. First injection of ketamine among young injection drug users (IDUs) in three U.S. cities. Drug Alcohol Depend., 2007, 87, 83-93.
7. Wood, D.M.; Nicolaou, M.; Dargan, P.I. Epidemiology of recreational drug toxicity in a nightclub environment. Subst. Use Misuse., 2009, 44, 1495-1502.
8. Weber, F.; Wulf, H.; el Saeidi, G. Premedication with nasal s-ketamine and midazolam provides good conditions for induction of anesthesia in preschool children. Can. J. Anaesth., 2003, 50, 470-475.
9. Yu, H.; Li, Q.; Wang, D.; Shi, L.; Lu, G.; Sun, L.; Wang, L.; Zhu, W.; Mak, Y.T.; Wong, N.; Wang, Y.; Pan, F.; Yew, D.T. Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI). Neurotoxicology, 2012, 33(1),70-77.
10. Yeung, L.Y.; Wai, M.S.; Fan, M.; Mak, Y.T.; Lam, W.P.; Li, Z; Lu, G; Yew, D.T. Hyperphosphorylated tau in the brains of mice and monkeys with long-term administration of ketamine. Toxicol. Lett., 2010, 193, 189-193.
11. Lorke, D.E.; Wai, M.S.; Liang, Y.; Yew, D.T. TUNEL and growth factor expression in the prefrontal cortex of Alzheimer patients over 80 years old. Int. J. Immunopathol. Pharmacol., 2010, 23, 13-23.
12. Wai, M.S.; Liang, Y.; Shi, C.; Cho, E.Y.; Kung, H.F.; Yew, D.T. Co-localization of hyperphosphorylated tau and caspases in the brainstem of Alzheimer's disease patients. Biogerontology, 2009, 10, 457-469.
13. Tan, S.; Rudd, J.A.; Yew, D.T. Gene expression changes in GABAA receptors and cognition following chronic ketamine administration in mice. Plos One., 2011, 6, e21328.
14. Mak, Y.T.; Lam, W.P.; Lü, L.; Wong, Y.W.; Yew, D.T. The toxic effect of ketamine on SH-SY5Y neuroblastoma cell line and human neuron. Microsc. Res. Tech., 2010, 73, 195-201.
15. Chan, W.M.; Xu, J.; Fan, M.; Tsui, Y.M.; Wai, S.M.; Lam, W.P.; Yew, D.T. Downregulation in the human and mice cerebella after ketamine versus ketamine plus ethanol treatment. Microsc. Res. Tech., 2011 (E. pub.).
16. Topping, D.C.; Bernard, L.G.; O'Donoghue, J.L.; English, J.C. Hydroquinone: acute and subchronic toxicity studies with emphasis on neurobehavioral and nephrotoxic effects. Food Chem. Toxicol., 2007, 45, 70-78.
17. Tan, S.; Chan, W.M.; Wai, M.S.; Hui, L.K.; Hui, V.W.; James, A.E.; Yeung, L.Y.; Yew, D.T. Ketamine effects on the urogenital system-changes in the urinary bladder and sperm motility. Microsc. Res. Tech., 2011, 74,1192-1198.
18. Yeung, L.Y.; Rudd, J.A.; Lam, W.P.; Mak, Y.T.; Yew, D.T. Mice are prone to kidney pathology after prolonged ketamine addiction. Toxicol. Lett., 2009, 191, 275-278.
19. Irifune, M.; Sato, T.; Kamata, Y.; Nishikawa, T.; Dohi, T.; Kawahara, M. Evidence for GABA(A) receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice. Anesth Analg., 2000, 91, 230-236.
20. Wai, S.M.; Chan, W.M.; Zhang, A.Q.; Wu, Y.; Yew, D.T. Long-term ketamine and ketamine plus alcohol treatments produced damages in liver and kidney. Hum. Exp. Toxicol., 2011. (In press)
21. Lee, S.T.; Wu, T.T.; Yu, P.Y.; Chen, R.M. Apoptotic insults to human HepG2 cells induced by S-(+)-ketamine occurs through activation of a Bax-mitochondria-caspase protease pathway. Br. J. Anaesth., 2009, 102, 80-89.
22. Noppers, I.M.; Niesters, M.; Aarts, L.P.; Bauer, M.C.; Drewes, A.M.; Dahan, A.; Sarton, E.Y. Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: A report of 3 cases. Pain., 2011, 152, 2173-2178.
23. Chan, W.M.; Liang, Y.; Wai, S.M.; Wong, Y.W.; Lam, L. H.; Hung, S. M.; Rudd, J.A.; Yew, D.T. Cardiotoxicity induced in mice by long term ketamine and ketamine plus alcohol. Toxicol. Lett., 2011, 207, 191-196.
24. Rollin, A.; Maury, P.; Guilbeau-Frugier, C.; Brugada, J. Transient ST elevation after ketamine intoxication: a new cause of acquired brugada ECG pattern. J. Cardiovasc. Electrophysiol., 2011, 22, 91-94.
25. Spotoft, H.; Korshin, J.D.; Sørensen, M.B.; Skovsted, P. The cardiovascular effects of ketamine used for induction of anaesthesia in patients with valvular heart disease. Can. Anaesth. Soc. J., 1979, 26, 463-467.
26. Willson, R.L. Hydroxyl radicals and biological damage in vitro: what relevance in vivo? Ciba Found Symp., 1978, 65, 19-42.
27. Bhutta A.T. Ketamine: A controversial drug for neonates. Semin Perinatol., 2007, 31, 303-308.
28. Chatterjee, M.; Ganguly, S.; Srivastava, M.; Palit, G. Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis. Behav. Brain Res., 2011, 216, 247-254.
29. Moore, N.N.; Bostwick, J.M. Ketamine dependence in anesthesia providers. Psychosomatics, 1999, 40, 356-359.
30. Dolin, S. J. Drugs and pharmacology (Nicholas L. Padfield, ed), Butterworth Heinemann: Oxford, 2000.
31. Shi, Q.; Guo, L.; Patterson, T.A.; Dial, S.; Li, Q.; Sadovova, N.; Zhang, X.; Hanig, J.P.; Paule, M.G.; Slikker, W. Jr.; Wang, C. Gene expression profiling in the developing rat brain exposed to ketamine. Neuroscience, 2010, 166, 852-863.
32. Hsu, H.R.; Mei, Y.Y.; Wu, C.Y.; Chiu, P.H.; Chen, H.H. Behavioural and toxic interaction profile of ketamine in combination with caffeine. Basic Clin. Pharmacol. Toxicol., 2009, 104, 379-383.